CVS Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeWall Street coverage
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 13.66
- PEG ratio
- 0.28
- P/B
- 1.66
- P/S (TTM)
- 0.32
- EV/EBITDA
- 17.52
Profitability & growth
- ROE (TTM)
- 3.8%
- Operating margin
- 4.1%
- Revenue growth YoY
- 6.1%
- Dividend yield
- 2.6%
- Beta
- 0.62
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
28 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About CVS Health Corp
Company profileCVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.
Classification
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- ONE CVS DRIVE, WOONSOCKET, RI
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
